Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 2
1967 1
1968 1
1969 1
1970 2
1971 2
1972 4
1973 1
1974 5
1976 2
1978 2
1981 1
1982 1
1984 2
1985 5
1986 1
1987 2
1988 5
1989 11
1990 2
1991 3
1992 3
1993 8
1994 5
1995 1
1996 5
1997 2
1998 5
1999 4
2000 2
2001 2
2002 7
2003 2
2004 1
2005 5
2006 6
2007 13
2008 11
2009 13
2010 13
2011 11
2012 31
2013 33
2014 30
2015 33
2016 35
2017 21
2018 39
2019 43
2020 43
2021 38
2022 34
Text availability
Article attribute
Article type
Publication date

Search Results

494 results
Results by year
Filters applied: . Clear all
Page 1
MDM2 inhibition: an important step forward in cancer therapy.
Konopleva M, Martinelli G, Daver N, Papayannidis C, Wei A, Higgins B, Ott M, Mascarenhas J, Andreeff M. Konopleva M, et al. Among authors: mascarenhas j. Leukemia. 2020 Nov;34(11):2858-2874. doi: 10.1038/s41375-020-0949-z. Epub 2020 Jul 10. Leukemia. 2020. PMID: 32651541 Review.
Novel therapeutics in myeloproliferative neoplasms.
Venugopal S, Mascarenhas J. Venugopal S, et al. Among authors: mascarenhas j. J Hematol Oncol. 2020 Dec 2;13(1):162. doi: 10.1186/s13045-020-00995-y. J Hematol Oncol. 2020. PMID: 33267911 Free PMC article. Review.
Peripheral arterial disease.
Mascarenhas JV, Albayati MA, Shearman CP, Jude EB. Mascarenhas JV, et al. Endocrinol Metab Clin North Am. 2014 Mar;43(1):149-66. doi: 10.1016/j.ecl.2013.09.003. Endocrinol Metab Clin North Am. 2014. PMID: 24582096 Review.
Novel Therapies in Polycythemia Vera.
Tremblay D, Mascarenhas J. Tremblay D, et al. Among authors: mascarenhas j. Curr Hematol Malig Rep. 2020 Apr;15(2):133-140. doi: 10.1007/s11899-020-00564-7. Curr Hematol Malig Rep. 2020. PMID: 32034662 Review.
Pacritinib vs Best Available Therapy, Including Ruxolitinib, in Patients With Myelofibrosis: A Randomized Clinical Trial.
Mascarenhas J, Hoffman R, Talpaz M, Gerds AT, Stein B, Gupta V, Szoke A, Drummond M, Pristupa A, Granston T, Daly R, Al-Fayoumi S, Callahan JA, Singer JW, Gotlib J, Jamieson C, Harrison C, Mesa R, Verstovsek S. Mascarenhas J, et al. JAMA Oncol. 2018 May 1;4(5):652-659. doi: 10.1001/jamaoncol.2017.5818. JAMA Oncol. 2018. PMID: 29522138 Free PMC article. Clinical Trial.
Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea.
Yacoub A, Mascarenhas J, Kosiorek H, Prchal JT, Berenzon D, Baer MR, Ritchie E, Silver RT, Kessler C, Winton E, Finazzi MC, Rambaldi A, Vannucchi AM, Leibowitz D, Rondelli D, Arcasoy MO, Catchatourian R, Vadakara J, Rosti V, Hexner E, Kremyanskaya M, Sandy L, Tripodi J, Najfeld V, Farnoud N, Papaemmanuil E, Salama M, Singer-Weinberg R, Rampal R, Goldberg JD, Barbui T, Mesa R, Dueck AC, Hoffman R. Yacoub A, et al. Among authors: mascarenhas j. Blood. 2019 Oct 31;134(18):1498-1509. doi: 10.1182/blood.2019000428. Blood. 2019. PMID: 31515250 Free PMC article. Clinical Trial.
494 results